AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.12B |
| 2 |
NYM
AB New York Intermediate Municipal ETF
NYM
|
+$1.11B |
| 3 |
Abbott
ABT
|
+$882M |
| 4 |
CAM
AB California Intermediate Municipal ETF
CAM
|
+$877M |
| 5 |
CORB
AB Core Bond ETF
CORB
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.49B |
| 2 |
Applied Materials
AMAT
|
+$1.52B |
| 3 |
Broadcom
AVGO
|
+$1.39B |
| 4 |
Netflix
NFLX
|
+$1.08B |
| 5 |
Meta Platforms (Facebook)
META
|
+$700M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.87% |
| 2 | Healthcare | 12.65% |
| 3 | Financials | 11.3% |
| 4 | Communication Services | 10.67% |
| 5 | Consumer Discretionary | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVBC
1926
Avidia Bancorp
AVBC
$413M
| $2.27M | ﹤0.01% |
134,876
+40,855
| +43% | +$641K |
|
1927
Immunovant
IMVT
$7.93B
| $2.27M | ﹤0.01% |
89,160
-463
| -0.5% | -$10.3K |
|
1928
QuidelOrtho
QDEL
$1.13B
| $2.25M | ﹤0.01% |
78,943
-651
| -0.8% | -$17.6K |
|
|
SEM
1929
DELISTED
Select Medical
SEM
| $2.25M | ﹤0.01% |
151,668
+20,040
| +15% | +$283K |
|
1930
Pitney Bowes
PBI
$2.39B
| $2.25M | ﹤0.01% |
212,879
+24,396
| +13% | +$253K |
|
1931
ACM Research
ACMR
$4.51B
| $2.25M | ﹤0.01% |
57,015
+7,048
| +14% | +$263K |
|
1932
United Natural Foods
UNFI
$3.04B
| $2.25M | ﹤0.01% |
66,769
-1,849
| -3% | -$68.7K |
|
1933
Ziff Davis
ZD
$2B
| $2.24M | ﹤0.01% |
63,857
+13,013
| +26% | +$454K |
|
|
WCN
1934
Waste Connections
WCN
$43.6B
| $2.24M | ﹤0.01% |
12,757
+3,238
| +34% | +$560K |
|
1935
Rapid7
RPD
$628M
| $2.23M | ﹤0.01% |
146,635
+25,729
| +21% | +$423K |
|
1936
Chemours
CC
$2.48B
| $2.22M | ﹤0.01% |
188,294
+20,408
| +12% | +$262K |
|
1937
National Healthcare
NHC
$3.57B
| $2.22M | ﹤0.01% |
16,176
+2,300
| +17% | +$297K |
|
1938
Atkore
ATKR
$2.41B
| $2.22M | ﹤0.01% |
35,060
-4,302
| -11% | -$281K |
|
1939
AvePoint
AVPT
$2.76B
| $2.21M | ﹤0.01% |
159,288
+259
| +0.2% | +$3.58K |
|
1940
Spyre Therapeutics
SYRE
$8.5B
| $2.21M | ﹤0.01% |
67,500
+31,270
| +86% | +$817K |
|
|
ELME
1941
Elme Communities
ELME
$145M
| $2.21M | ﹤0.01% |
126,974
+20,074
| +19% | +$340K |
|
1942
S&T Bancorp
STBA
$1.9B
| $2.21M | ﹤0.01% |
56,088
+7,460
| +15% | +$288K |
|
|
LTC
1943
LTC Properties
LTC
$2.13B
| $2.2M | ﹤0.01% |
64,018
+385
| +0.6% | +$13.6K |
|
1944
Kinetik
KNTK
$3.72B
| $2.2M | ﹤0.01% |
60,928
+7,442
| +14% | +$269K |
|
1945
Worthington Enterprises
WOR
$2.74B
| $2.19M | ﹤0.01% |
42,417
+5,274
| +14% | +$291K |
|
1946
Rogers Corp
ROG
$2.08B
| $2.19M | ﹤0.01% |
23,886
+3,519
| +17% | +$302K |
|
1947
Global Net Lease
GNL
$1.87B
| $2.18M | ﹤0.01% |
253,996
-13,009
| -5% | -$104K |
|
1948
Minerals Technologies
MTX
$2.29B
| $2.18M | ﹤0.01% |
35,829
| – | – |
|
1949
Madison Square Garden
MSGE
$3.59B
| $2.18M | ﹤0.01% |
40,440
-1,200
| -3% | -$57.7K |
|
1950
Alamo Group
ALG
$1.91B
| $2.17M | ﹤0.01% |
12,941
+1,421
| +12% | +$247K |
|
Similar funds
AllianceBernstein's Q4 2025 Portfolio in Review
As of Q4 2025, AllianceBernstein held 3,321 positions worth $317B, down 0.28% from $318B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 5%. AllianceBernstein opened 80 new positions and exited 86, leaving the 3,321-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q4 2025 buy was AB New York Intermediate Municipal ETF: 44,446,807 shares worth $1.11B.
- AllianceBernstein added most to Apple in Q4 2025, an estimated $3.12B increase.
- AllianceBernstein's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $2.49B.
- AllianceBernstein fully exited Merus in Q4 2025, selling an estimated $113M.
- AllianceBernstein's ten largest holdings make up 33% of its $317B portfolio in Q4 2025.
- AllianceBernstein opened 80 new positions and closed 86 in Q4 2025.
- AllianceBernstein's portfolio value fell 0.28% quarter-over-quarter to $317B.
Based on AllianceBernstein's 13F filing for Q4 2025, filed 17 Feb 2026.